Your browser doesn't support javascript.
Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19.
Wilcox, Tanya; Smilowitz, Nathaniel R; Seda, Bilaloglu; Xia, Yuhe; Hochman, Judith; Berger, Jeffrey S.
  • Wilcox T; The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.
  • Smilowitz NR; The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.
  • Seda B; The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.
  • Xia Y; The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.
  • Hochman J; The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York.
  • Berger JS; The Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York. Electronic address: jeffrey.berger@nyumc.org.
Am J Cardiol ; 170: 112-117, 2022 05 01.
Article in English | MEDLINE | ID: covidwho-1787987
ABSTRACT
Gender-specific differences in thrombosis have been reported in hospitalized patients with COVID-19. We sought to investigate the influence of age on the relation between gender and incident thrombosis or death in COVID-19. We identified consecutive adults aged ≥18 years hospitalized with COVID-19 from March 1, 2020, to April 17, 2020, at a large New York health system. In-hospital thrombosis and all-cause mortality were evaluated by gender and stratified by age group. Logistic regression models were generated to estimate the odds of thrombosis or death after multivariable adjustment. In 3,334 patients hospitalized with COVID-19, 61% were men. Death or thrombosis occurred in 34% of hospitalizations and was more common in men (36% vs 29% in women, p <0.001; adjusted odds ratio [aOR] 1.61, 95% confidence interval [CI] 1.36 to 1.91). When stratified by age, men had a higher incidence of death or thrombosis in younger patients (aged 18 to 54 years 21% vs 9%, aOR 3.17, 95% CI 2.06 to 5.01; aged 55 to 74 years 39% vs 28%, aOR 1.63, 95% CI 1.28 to 2.10), but not older patients (aged ≥75 years 55% vs 48%; aOR 1.20, 95% CI 0.90 to 1.59) (interaction p value 0.01). For the individual end points, men were at higher risk of thrombosis (19% vs 12%; aOR 1.65, 95% CI 1.33 to 2.05) and mortality (26% vs 23%; aOR 1.41, 95% CI 1.17 to 1.69) than women, and gender-specific differences were attenuated with older age. Associations between thrombosis and mortality were most striking in younger patients (aged 18 to 54 years, aOR 8.25; aged 55 to 74 years, aOR 2.38; aged >75 years, aOR 1.88; p for interaction <0.001) but did not differ by gender. In conclusion, the risk of thrombosis or death in COVID-19 is higher in men compared with women and is most apparent in younger age groups.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Am J Cardiol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Am J Cardiol Year: 2022 Document Type: Article